ReviewRetrograde signaling by endocannabinoids
Introduction
Although the psychoactive properties of the marijuana plant, Cannabis sativa, have been known for thousands of years, the existence of receptors that bind the active compound, Δ9-tetrahydrocannabinol, has only recently been documented 1., 2.. This discovery suggested the presence of an endogenous signaling system that could utilize these widely expressed receptors. Subsequently, several arachidonic acid derivatives that activate the cannabinoid receptor were isolated, including arachidonylethanolamide (anandamide) [3] and 2-arachidonylglycerol (2-AG) 4., 5.. The formation of these endogenous cannabinoids, or endocannabinoids, is stimulated by calcium 6., 7. and mechanisms have been proposed for their transport and enzymatic degradation 8., 9., 10.. Although these reports firmly established the existence of an endocannabinoid signaling system, its functional role in the brain was not well understood.
As the endocannabinoid system was being discovered, parallel studies revealed a phenomenon known as depolarization-induced suppression of inhibition (DSI) 11., 12., 13.. DSI has been studied in the cerebellum and the hippocampus, although it is likely present in other brain regions as well. It occurs following depolarization of a postsynaptic neuron and is characterized by a transient presynaptic suppression of inhibitory postsynaptic currents (IPSCs). Initial reports indicated that DSI is triggered in response to a rise in postsynaptic calcium levels and involves a retrograde messenger released by the postsynaptic cell 11., 12., 14., 15.. However, until last year, despite extensive characterization of DSI in the cerebellum and hippocampus, several outstanding issues remained. It was not known whether DSI was restricted to inhibitory synapses in the hippocampus and cerebellum or whether it represented a more general type of synaptic regulation. In addition, the identity of the retrograde messenger and its mechanism of action had not been determined.
Recent studies indicate that endocannabinoids mediate the rapid retrograde suppression of both excitatory and inhibitory synapses 16••., 17••., 18••.. Here, we briefly overview the endocannabinoid system (for more extensive reviews, see 19., 20., 21., 22., 23., 24.). We then focus on recent studies in the hippocampus and cerebellum that highlight a role for retrograde signaling by endocannabinoids in the central nervous system.
Section snippets
The cannabinoid receptor
Most physiological effects of cannabinoids are mediated through specific receptors. Initial characterization of the cannabinoid receptor [1] and its distribution in vertebrate brain [25] utilized a high-affinity radiolabeled cannabinoid agonist. The highest levels of cannabinoid binding were found in the basal ganglia, cerebellum, hippocampus, and cortex. The receptor, which was cloned and identified as a seven-transmembrane domain G-protein-coupled receptor [2], is prominently expressed in the
Retrograde signaling by endocannabinoids
Recent studies have resolved many issues regarding retrograde synaptic inhibition and the role of cannabinoid signaling in the brain. In addition to suppressing inhibitory synapses, postsynaptic depolarization can modulate excitatory synapses, through a process known as depolarization-induced suppression of excitation (DSE) [18••]. Furthermore, experiments have established that endocannabinoids are the retrograde messengers for DSI in the hippocampus 16••., 17••. (Fig. 2b) and for both DSI and
Mechanisms of synaptic inhibition by cannabinoids
The primary mechanism by which endocannabinoids suppress synaptic inputs is though CB1 receptor-mediated activation and G-protein-mediated inhibition of presynaptic calcium channels. This has been demonstrated at the climbing fiber to Purkinje cell synapse during DSE, by imaging presynaptic calcium influx evoked by an action potential [18••]. Purkinje cell depolarization decreased calcium entry with a time course similar to that of excitatory postsynaptic current (EPSC) suppression, and this
Physiological significance
Although depolarization of voltage-clamped neurons provides a simple protocol to elicit calcium influx and endocannabinoid formation, it is also important to consider what types of stimuli give rise to DSI and DSE under more realistic conditions. In the hippocampus, repetitive firing (20 Hz, 2 s) in CA1 pyramidal cells elicits DSI [12], and repetitive stimulation (50 Hz, 3–5 s) of synaptic inputs onto cells in hippocampal cultures also results in suppression of GABA release [17••]. In the
Conclusions and future directions
Endocannabinoids are lipophilic signaling molecules, which are synthesized de novo from membrane phospholipids in response to postsynaptic depolarization or mGluR activation. They can diffuse to nearby presynaptic terminals where they suppress neurotransmitter release by inhibiting calcium channels. The timecourse of endocannabinoid modulation is longer than the ∼1 s inhibition produced by local GABA release [71] and much more rapid than activity-dependent synaptic scaling, which requires hours
Update
A recent study in the cerebellum has confirmed that DSI is mediated by endocannabinoids [73]. This study found that cerebellar DSI — similarly to previous results concerning hippocampal DSI — requires CB1 receptors, because DSI is absent in CB1 knockout mice, [54•]. Another study in the hippocampus found that endocannabinoid release following depolarization is enhanced nonlinearly in the presence of a postsynaptic mGluR agonist, suggesting that multiple signaling pathways may converge to
Acknowledgments
We thank Dawn Blitz, Stephan Brenowitz, Solange Brown, Adam Carter, Kelly Foster, Patrick Safo, and Matthew Xu-Friedman for comments on the manuscript.
References and recommended reading
Papers of particular interest, published within the annual period of review, have been highlighted as:
• of special interest
•• of outstanding interest
References (78)
- et al.
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
Biochem Pharmacol
(1995) - et al.
2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain
Biochem Biophys Res Commun
(1995) - et al.
Calcium entry increases the sensitivity of cerebellar Purkinje cells to applied GABA and decreases inhibitory synaptic currents
Neuron
(1991) - et al.
Retrograde signaling at GABAA-receptor synapses in the mammalian CNS
Trends Neurosci
(1995) - et al.
Neighboring cerebellar Purkinje cells communicate via retrograde inhibition of common presynaptic interneurons
Neuron
(1993) - et al.
Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals
Neuron
(2001) - et al.
Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells
Neuron
(2001) - et al.
Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action
Trends Neurosci
(1998) - et al.
Discovery and characterization of endogenous cannabinoids
Life Sci
(1999) The effects of cannabinoids on the brain
Prog Neurobiol
(1999)
Modulation of transmitter release via presynaptic cannabinoid receptors
Trends Pharmacol Sci
Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry
Neuroscience
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Neuroscience
Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry
Neurosci Lett
Immunohistochemical localization of phospholipase D1 in rat central nervous system
Brain Research
Anandamide, an endogenous cannabinoid, inhibits Shaker-related voltage-gated K+ channels
Neuropharmacology
The cannabinoid agonist Win55,212-2 inhibits calcium channels by receptor-mediated and direct pathways in cultured rat hippocampal neurons
Brain Res
Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes
Neurosci Lett
Presynaptic specificity of endocannabinoid signaling in the hippocampus
Neuron
Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation
Neuroscience
Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus
Neuroscience
Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors
Neuron
Receptor-dependent formation of endogenous cannabinoids in cortical neurons
Euro J Pharmacol
Interactions between distinct GABAA circuits in hippocampus
Neuron
Either N- or P-type calcium channels mediate GABA release at distinct hippocampal inhibitory synapses
Neuron
Determination and characterization of a cannabinoid receptor in rat brain
Mol Pharmacol
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Nature
Isolation and structure of a brain constituent that binds to the cannabinoid receptor
Science
Formation and inactivation of endogenous cannabinoid anandamide in central neurons
Nature
A second endogenous cannabinoid that modulates long-term potentiation
Nature
Functional role of high-affinity anandamide transport, as revealed by selective inhibition
Science
Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion
J Neurochem
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Nature
Postsynaptic spike firing reduces synaptic GABAA responses in hippocampal pyramidal cells
J Neurosci
Depolarization-induced suppression of GABAergic inhibition in rat hippocampal pyramidal cells: G-protein involvement in a presynaptic mechanism
Neuron
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
Nature
Pharmacology of cannabinoid receptor ligands
Curr Med Chem
The neurobiology and evolution of cannabinoid signalling
Phil Trans R Soc Biol Sci
Cannabinoid receptor localization in brain
Proc Natl Acad Sci USA
Cited by (187)
Inhibiting degradation of 2-arachidonoylglycerol as a therapeutic strategy for neurodegenerative diseases
2023, Pharmacology and TherapeuticsCannabinoids and endocannabinoid signaling at the basal forebrain cholinergic system
2023, Cannabis Use, Neurobiology, Psychology, and TreatmentCannabis exposure during adolescence: A uniquely sensitive period for neurobiological effects
2022, International Review of NeurobiologyIntegrative analysis of the metabolome and transcriptome reveals seed germination mechanism in Punica granatum L.
2021, Journal of Integrative AgricultureCannabinoids in the descending pain modulatory circuit: Role in inflammation
2020, Pharmacology and Therapeutics